Firebrick Pharma Limited (ASX:FRE)

Firebrick Pharma Revenue

In the fiscal year ending June 30, 2026, Firebrick Pharma had annual revenue of 135.62K AUD, down -73.69%. Firebrick Pharma had revenue of 43.36K in the half year ending June 30, 2026, a decrease of -95.36%. That makes Firebrick Pharma the 46,151st largest company in the world by revenue and 1,238th in Australia.

• Revenue: 135.62K
• Revenue Growth: -73.69%
• P/S Ratio: 63.61
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 8.63M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Asia 58.37K 55.0%
• North America 46.19K 43.6%
• Europe and Others 1.47K 1.4%

Fiscal year ended Jun 30, 2026 See the full Firebrick Pharma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	135.62K	-379.89K	-73.69%
Jun 30, 2025	515.51K	-2.23M	-81.26%
Jun 30, 2024	2.75M	2.73M	12,096.48%
Jun 30, 2023	22.55K	-1.06M	-97.92%
Jun 30, 2022	1.08M	661.35K	156.72%

Data Source: S&P Global Market Intelligence Last updated: Aug 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 9, 2026

Data Sources Report a data error